04.05.2021 05:01:48
|
Chemours Q1 Profit Down
(RTTNews) - Chemours Co. (CC) reported that its first quarter net income declined to $96 million or $0.57 per share from $100 million or $0.61 per share in the prior year.
Adjusted earnings per share was $0.71, same with the prior year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.63 per share for the quarter. Analysts' estimates typically exclude special items.
Net sales were $1.44 billion, 10% higher than the prior-year quarter, which included a negative 1% portfolio impact from the exit of the aniline business. Analysts expected revenue of $1.4 billion for the quarter.
The company now expects to deliver 2021 Adjusted EBITDA within a range of $1.1 billion to $1.25 billion and to generate greater than $450 million of Free Cash Flow.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu The Chemours Co When Issuedmehr Nachrichten
03.11.24 |
Ausblick: The Chemours öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
20.10.24 |
Erste Schätzungen: The Chemours präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) |
Analysen zu The Chemours Co When Issuedmehr Analysen
Aktien in diesem Artikel
The Chemours Co When Issued | 17,34 | -0,46% |
|